0001567619-21-016019.txt : 20210818
0001567619-21-016019.hdr.sgml : 20210818
20210818065907
ACCESSION NUMBER: 0001567619-21-016019
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210812
FILED AS OF DATE: 20210818
DATE AS OF CHANGE: 20210818
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Helsel Dave
CENTRAL INDEX KEY: 0001543753
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50761
FILM NUMBER: 211184983
MAIL ADDRESS:
STREET 1: 400 WOOD ROAD
CITY: BRAINTREE
STATE: MA
ZIP: 02184
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ANGIODYNAMICS INC
CENTRAL INDEX KEY: 0001275187
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 113146460
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0531
BUSINESS ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
BUSINESS PHONE: 5187981215
MAIL ADDRESS:
STREET 1: 14 PLAZA DRIVE
CITY: LATHAM
STATE: NY
ZIP: 12110
4/A
1
doc1.xml
FORM 4/A
X0306
4/A
2021-08-12
2021-08-17
0
0001275187
ANGIODYNAMICS INC
ANGO
0001543753
Helsel Dave
14 PLAZA DRIVE
LATHAM
NY
12110
0
1
0
0
SVP Global Operations and R&D
Common Stock
2021-08-12
4
M
0
11406
0
A
33228
D
Common Stock
2021-08-12
4
F
0
3347
27.29
D
29881
D
Performance Right
2021-08-12
4
M
0
9834
0
D
Common Stock
9834
0
D
On August 17, 2021, the reporting person filed a Form 4 to report the vesting and settlement of performance share units and the sale of certain underlying shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), which contained administrative errors as to the terms of the performance share units and the number of shares of Common Stock of the Company issued and sold.
This acquisition of 11,406 shares of Common Stock of the Company represents shares acquired through the vesting and settlement of performance share units granted to the reporting person on July 18, 2018.
The exempt disposition of 3,347 shares of Common Stock of the Company was made to satisfy tax withholding obligations in connection with the pre-determined vesting of shares underlying performance share units granted to the reporting person on July 18, 2018.
On July 18, 2018, the reporting person received a target grant of 9,834 performance share units. Between 0% and 200% of the target number was to be earned based on total shareholder return relative to a peer group of companies over a three-year performance period ending May 31, 2021. Based on performance over the period, 11,406 shares of Common Stock were issued to the reporting person under this grant.
/s/ Richard C. Rosenzweig, Attorney in Fact
2021-08-17